UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002807
Receipt number R000003416
Scientific Title Evaluation of reference interval and cutoff value of ProGRP in serum and plasma
Date of disclosure of the study information 2009/11/27
Last modified on 2009/11/27 18:32:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of reference interval and cutoff value of ProGRP in serum and plasma

Acronym

Evaluation of reference interval and cutoff value of ProGRP in serum and plasma

Scientific Title

Evaluation of reference interval and cutoff value of ProGRP in serum and plasma

Scientific Title:Acronym

Evaluation of reference interval and cutoff value of ProGRP in serum and plasma

Region

Japan


Condition

Condition

small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of reference interval and cutoff value of ProGRP in serum and plasma

Basic objectives2

Others

Basic objectives -Others

Evaluation of reference interval and cutoff value

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Reference interval and cutoff value of ProGRP in serum and plasma

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Blood draw

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 Small cell lung cancer,non small cell lung cancer, benign respiratory diseases
1) Aged 20 years or older
2) Written informed consent
3) Diagnosed as SCLC or NSCLC cytologically or histologically / diagnosed as benign respiratory diseases

2 Healthy subject
1) Aged 20 years or older
2) Written informed consent

Key exclusion criteria

1 Small cell lung cancer, non small cell lung cancer, benign respiratory diseases
1) Not applicable

2 Healthy subject
1) Abnormal shadow by X rays of chest within a year
2) Abnormal creatinine value
3) Renal disorder
4) Hepatic disorder

Target sample size

1534


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobuyuki Yamamoto

Organization

Shizuoka Cancer Center

Division name

Division of Thoracic Oncology

Zip code


Address

1007 Shimonagakubo, Nagaizumi-cho,Sunto-gun, Shizuoka 411-8777,Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Shizuoka Cancer Center

Division name

Division of Thoracic Oncology

Zip code


Address

1007 Shimonagakubo, Nagaizumi-cho,Sunto-gun, Shizuoka 411-8777,Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Pharma Valley Center, the Shizuoka Organization of Creation Industries

Institute

Department

Personal name



Funding Source

Organization

Pharma Valley Center, the Shizuoka Organization of Creation Industries

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 11 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2009 Year 11 Month 25 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date

2010 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 11 Month 27 Day

Last modified on

2009 Year 11 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003416


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name